Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TRANMER, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TRANMER, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1978 British Society for Rheumatology


research-article

BENORYLATE VERSUS IBUPROFEN IN THE TREATMENT OF OSTEOARTHRITIS

C. TRANMER

Department of Rheumatology and Rehabilitation, King George and Barking Hospitals Essex

Correspondence to: Requests for reprints to Dr. C. Tranmer, 23 King's Avenue, Buckhurst Hill, Essex.

Benorylate tablets 4.5 g daily were compared with ibuprofen tablets 600 mg daily in the symptomatic treatment of osteoarthritis over a two-week period. Both treatments conferred benefit equally in relief of pain at rest, but the relief of pain on using the joints was significantly better at day 14 in the benorylate group. When the patients' own assessments of general effectiveness of the treatments were analysed, there was a statistically significant response in the males in favour of benorylate. There was no difference between the two treatments in the females, but the initial overall severity of the disease was greater in the females in the benorylate group. Both drugs were well tolerated.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.